Itch-/- αβ and γδ T cells independently contribute to autoimmunity in Itchy mice

Blood

Volumn 111, Issue 8, 2008, Pages 4273-4282

  Parravicini, Valentino ^a   Field, Anne Christine ^a   Tomlinson, Peter D ^a   Basson, M Albert ^b   Zamoyska, Rose ^a,c  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; PROTEIN ITCH; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ANTIBODY; IMMUNOGLOBULIN E; INTERLEUKIN 4; ITCH PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; UBIQUITIN PROTEIN LIGASE;

ALPHABETA T LYMPHOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B1B LYMPHOCYTE; CONTROLLED STUDY; GAMMADELTA T LYMPHOCYTE; GENE; INFLAMMATION; ITCH GENE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; BLOOD; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL POLARITY; CELL PROLIFERATION; CYTOLOGY; ENZYMOLOGY; EXUDATE; HEMATOPOIETIC SYSTEM; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PERITONEUM; SPLEEN; TH2 CELL;

ANIMALS; ANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CELL POLARITY; CELL PROLIFERATION; EXUDATES AND TRANSUDATES; HEMATOPOIETIC SYSTEM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PERITONEUM; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SPLEEN; T-LYMPHOCYTES; TH2 CELLS; UBIQUITIN-PROTEIN LIGASES;

EID: 43249113671     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-10-115667     Document Type: Article

References (53)

1. Lanier LL. Face off: the interplay between activating and inhibitory immune receptors. Curr Opin Immunol. 2001;13:326-331.
2. Angers A, Ramjaun AR, McPherson PS. The HECT domain ligase itch ubiquitinates endophilin and localizes to the trans-Golgi network and endosomal system. J Biol Chem. 2004;279:11471-11479.
3. Bonifacino JS, Traub LM. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem. 2003;72:395-447.
4. Schwartz AL, Ciechanover A. The ubiquitinproteasome pathway and pathogenesis of human diseases. Annu Rev Med. 1999;50:57-74.
5. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immunol. 2002;3:20-26.
6. Bachmaier K, Krawczyk C, Kozieradzki I, et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature. 2000;403:211-216.
7. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15:70-73.
8. Lupher ML Jr, Rao N, Eck MJ, Band H. The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction. Immunol Today. 1999;20:375-382.
9. Stebbins CE, Kaelin WG Jr, Pavletich NP. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science. 1999;284:455-461.
10. Vinuesa CG, Cook MC, Angelucci C, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature. 2005;435:452-458.
11. Perry WL, Hustad CM, Swing DA, O'Sullivan TN, Jenkins NA, Copeland NG. The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice. Nat Genet. 1998;18:143-146.
12. Hustad CM, Perry WL, Siracusa LD, et al. Molecular genetic characterization of six recessive viable alleles of the mouse agouti locus. Genetics. 1995;140:255-265.
13. Liu YC. Ubiquitin ligases and the immune response. Annu Rev Immunol. 2004;22:81-127.
14. Heissmeyer V, Macian F, Im SH, et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol. 2004;5:255-265.
15. Fang D, Elly C, Gao B, et al. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat Immunol. 2002;3:281-287.
16. Gao M, Labuda T, Xia Y, et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science. 2004;306:271-275.
17. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat Rev Immunol. 2004;4:348-359.
18. Scharschmidt E, Wegener E, Heissmeyer V, Rao A, Krappmann D. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. Mol Cell Biol. 2004;24:3860-3873.
19. Chang L, Kamata H, Solinas G, et al. The E3 ubiquitin ligase itch couples JNK activation to TN-Falpha-induced cell death by inducing c-FLIP(L) turnover. Cell. 2006;124:601-613.
20. Cornell M, Evans DA, Mann R, et al. The Drosophila melanogaster Suppressor of deltex gene, a regulator of the Notch receptor signaling pathway, is an E3 class ubiquitin ligase. Genetics. 1999;152:567-576.
21. Qiu L, Joazeiro C, Fang N, et al. Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase. J Biol Chem. 2000;275:35734-35737.
22. Benson RA, Adamson K, Corsin-Jimenez M, et al. Notchl co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 production. Eur J Immunol. 2005;35:859-869.
23. Lehar SM, Dooley J, Farr AG, Bevan MJ. Notch ligands Delta 1 and Jagged 1 transmit distinct signals to T-cell precursors. Blood. 2005;105:1440-1447.
24. Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell. 2004;117:515-526.
25. Witt CM, Won WJ, Hurez V, Klug CA. Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. J Immunol. 2003;171:2783-2788.
26. Kuroda K, Han H, Tani S, et al. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity. 2003;18:301-312.
27. Mohrs M, Shinkai K, Mohrs K, Locksley RM. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity. 2001;15:303-311.
28. Janas ML, Hodgkin P, Hibbs M, Tarlinton D. Genetic evidence for Lyn as a negative regulator of IL-4 signaling. J Immunol. 1999;163:4192-4198.
29. Nishizumi H, Taniuchi I, Yamanashi Y, et al. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 1995;3:549-560.
30. Majeti R, Xu Z, Parslow TG, et al. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell. 2000;103:1059-1070.
31. Xu Z, Duan B, Croker BP, Wakeland EK, Morel L. Genetic dissection of the murine lupus susceptibility locus Sle2: contributions to increased peritoneal B-1a cells and lupus nephritis map to different loci. J Immunol. 2005;175:936-943.
32. Sidman CL, Shultz LD, Hardy RR, Hayakawa K, Herzenberg LA. Production of immunoglobulin isotypes by Ly-1 + B cells in viable motheaten and normal mice. Science. 1986;232:1423-1425.
33. Hibbs ML, Tarlinton DM, Armes J, et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell. 1995;83:301-311.
34. Stickler M, Harding F. Peritoneal B-cell development depends on strain, radiation, and time. Exp Hematol. 2001;29:221-227.
35. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol. 1993;11:501-538.
36. Wen L, Roberts SJ, Viney JL, et al. Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cells. Nature. 1994;369:654-658.
37. Hsu MC, Toellner KM, Vinuesa CG, Maclennan IC. B cell clones that sustain long-term plasma-blast growth in T-independent extrafollicular antibody responses. Proc Natl Acad Sci U S A. 2006;103:5905-5910.
38. Surh CD, Boyman O, Purton JF, Sprent J. Homeostasis of memory T cells. Immunol Rev. 2006;211:154-163.
39. McCoy KD, Harris NL, Diener P, et al. Natural IgE production in the absence of MHC Class II cognate help. Immunity. 2006;24:329-339.
40. Erazo A, Kutchukhidze N, Leung M, et al. Unique maturation program of the IgE response in vivo. Immunity. 2007;26:191-203.
41. Nunez-Cruz S, Aguado E, Richelme S, et al. LAT regulates gammadelta T cell homeostasis and differentiation. Nat Immunol. 2003;4:999-1008.
42. Oliver PM, Cao X, Worthen GS, et al. Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation. Immunity. 2006;25:929-940.
43. McGill MA, McGlade CJ. Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem. 2003;278:23196-23203.
44. Tanigaki K, Kuroda K, Han H, Honjo T. Regulation of B cell development by Notch/RBP-J signaling. Semin Immunol. 2003;15:113-119.
45. Cariappa A, Pillai S. Antigen-dependent B-cell development. Curr Opin Immunol. 2002;14:241-249.
46. Tanigaki K, Han H, Yamamoto N, et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat Immunol. 2002;3:443-450.
47. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol. 2002;20:253-300.
48. Montecino-Rodriguez E, Leathers H, Dorshkind K. Identification of a B-1 B cell-specified progenitor. Nat Immunol. 2006;7:293-301.
49. Tung JW, Mrazek MD, Yang Y, Herzenberg LA, Herzenberg LA. Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse. Proc Natl Acad Sci U S A. 2006;103:6293-6298.
50. Hardy RR. Hayakawa K. A developmental switch in B lymphopoiesis. Proc Natl Acad Sci U S A. 1991;88:11550-11554.
51. Vink A, Warnier G, Brombacher F, Renauld JC. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med. 1999;189:1413-1423.
52. Casola S, Otipoby KL, Alimzhanov M, et al. B cell receptor signal strength determines B cell fate. Nat Immunol. 2004;5:317-327.
53. Itakura A, Kikuchi Y, Kouro T, et al. Interleukin 5 plays an essential role in elicitation of contact sensitivity through dual effects on eosinophils and B-1 cells. Int Arch Allergy Immunol. 2006;140(suppl 1):8-16.